文献速递肾小球疾病肾移植

抗podocin和抗KIRREL1抗体与自身免疫性足细胞病激素抵抗、FSGS及移植后复发相关

Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies.
PubMed 文献 · J Am Soc Nephrol · 2026-07-23

该多中心研究整合血清学与超分辨显微术,分析471份样本,发现抗slit膜蛋白抗体见于67/213例患者,其中63%为抗nephrin、9%为抗podocin或3%为抗KIRREL1单抗体,25%为多抗体。孤立抗nephrin抗体与微小病变(91%)、激素敏感(88%)及120个月内无CKD相关;抗podocin和/或抗KIRREL1抗体与FSGS(84%)、激素抵抗(58%)、CKD进展(36%)及肾衰竭(24%)相关。26例FSGS移植受者中,自身抗体携带者移植后早期复发83%,非携带者5%。

要点

  • 抗podocin/KIRREL1抗体与FSGS、激素抵抗及移植后复发相关。
  • 孤立抗nephrin抗体与微小病变、激素敏感及无CKD相关。
  • 移植后复发患者检出抗podocin/KIRREL1抗体(伴或不伴抗nephrin)。

核心结论

  • 抗podocin和抗KIRREL1抗体与自身免疫性足细胞病的激素抵抗、FSGS及移植后疾病复发相关。

研究设计与样本

  • 多中心研究,整合血清学与超分辨显微术,共471份样本,包括213例患者(146份肾活检:微小病变63例、FSGS83例)及128例患者血清(微小病变30例、FSGS42例、特发性肾病综合征或孤立性蛋白尿56例),含61份配对标本及258份对照(75份肾活检、200份血清,含17份配对标本)。

主要发现

  • 抗slit膜蛋白抗体在67/213例患者中检出:63%仅有抗nephrin、9%仅有抗podocin或3%仅有抗KIRREL1抗体,25%有多种自身抗体。
  • 孤立抗nephrin抗体与微小病变(91%)、激素敏感(88%)及120个月内无CKD相关。
  • 抗podocin和/或抗KIRREL1抗体与FSGS(84%)、激素抵抗(58%)、CKD进展(36%)及肾衰竭(24%)相关。
  • 26例FSGS移植受者中,自身抗体携带者移植后早期复发83%,非携带者5%;复发患者显示抗podocin/KIRREL1抗体,伴或不伴抗nephrin。

关键数值与推荐

  • 所有检测方法均显示高特异性,但敏感性低于超分辨显微术。

临床怎么用

  • 检测抗nephrin、抗podocin和抗KIRREL1抗体可改善风险分层,识别CKD及移植后复发高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Anti-slit autoantibody profiles identified different podocytopathy phenotypes, with anti-podocin/KIRREL1 associated with FSGS and steroid resistance. Anti-nephrin, anti-podocin, and anti-KIRREL1 testing improved risk stratification, identifying patients at a risk of CKD and post-transplant recurrence. BACKGROUND: Anti-nephrin, anti-podocin, and anti-KIRREL1 antibodies are increasingly recognized as causes of autoimmune podocytopathies, yet autoantibody-specific clinical phenotypes remain poorly defined. METHODS: We conducted a multicenter study integrating serology and super-resolution microscopy in 471 samples, including 213 cases with 146 kidney biopsies (minimal change n =63, FSGS n =83), and sera from 128 patients (minimal changes n =30, FSGS n =42, idiopathic nephrotic syndrome or isolated proteinuria n =56), including 61 paired specimens plus 258 controls (75 kidney biopsies, 200 sera, including 17 paired specimens). Paired specimens were used to assess ELISA performance by comparing serum results with IgG colocalization of target proteins within the filtration slit using receiver operating characteristic curves. All assays showed high specificity but lower sensitivity than super-resolution microscopy. Clinical features and long-term outcomes associated with individual autoantibodies and their combinations were also evaluated. RESULTS: Anti-slit diaphragm antibodies were detected in 67/213 patients: 63% had anti-nephrin, 9% anti-podocin, or 3% anti-KIRREL1 antibodies only, while 25% had multiple autoantibodies. Isolated anti-nephrin antibodies were associated with minimal changes (91%), steroid sensitivity (88%), and absence of CKD over 120 months. In contrast, anti-podocin and/or anti-KIRREL1 antibodies correlated with FSGS (84%), steroid resistance (58%), CKD progression (36%), and kidney failure (24%). Among 26 transplant recipients with FSGS, early post-transplant recurrence occurred in 83% of autoantibodies carriers and in 5% of the others. Recurrent patients showed anti-podocin/KIRREL1 antibodies, with or without anti-nephrin. CONCLUSIONS: These findings suggest that anti-podocin and anti-KIRREL1 antibodies associate with steroid resistance, FSGS, and disease recurrence after transplantation in autoimmune podocytopathies.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Raglianti V, Angelotti ML, Cirillo L, et al. Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies. J Am Soc Nephrol. 2026. PMID: 42490149. doi:10.1681/ASN.0000001195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。